MiR-195 inhibits myocardial fibrosis in hypertensive rats by regulating TGFβ1-Smad3 signaling pathway
Q. Xu, X.-X. Lin, P. Liu, W. Zhang, K. Tang, Y.-S. Zhai, L.-J. Liu, W.-Y. Mei Department of Cardiology, East Hospital, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
The article “MiR-195 inhibits myocardial fibrosis in hypertensive rats by regulating TGFβ1-Smad3 signaling pathway, by Q. Xu, X.-X. Lin, P. Liu, W. Zhang, K. Tang, Y.-S. Zhai, L.-J. Liu, W.-Y. Mei, published in Eur Rev Med Pharmacol Sci 2019; 23 (18): 8087-8094–DOI: 10.26355/eurrev_201909_19026–PMID: 31599435” has been withdrawn from the authors.
The Publisher apologizes for any inconvenience this may cause.
https://www.staging.europeanreview.org/article/19026
Free PDF Download
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
To cite this article
Q. Xu, X.-X. Lin, P. Liu, W. Zhang, K. Tang, Y.-S. Zhai, L.-J. Liu, W.-Y. Mei
MiR-195 inhibits myocardial fibrosis in hypertensive rats by regulating TGFβ1-Smad3 signaling pathway
Eur Rev Med Pharmacol Sci
Year: 2020
Vol. 24 - N. 15
Pages: 7919-7919
DOI: 10.26355/eurrev_202008_22453